Literature DB >> 27354890

Ferrofluid-associated Cutaneous Dyschromia: Discoloration of Hand and Fingers Following Accidental Exposure to Ferromagnetic Fluid.

Philip R Cohen1, Kenneth S Arfa2.   

Abstract

BACKGROUND: Ferrofluid is a colloidal suspension that usually consists of surfactant-coated nanoparticles of magnetite (Fe3O4) in a carrier liquid. Ferromagnetic fluid forms spikes when the liquid is exposed to a magnetic field.
PURPOSE: The authors describe a man who developed temporary discoloration of his right palm and fingers after accidental cutaneous contact with ferrofluid and discuss some of the current and potential applications of this unique liquid.
METHODS: A 28-year-old man was evaluating the effects of magnetic fields using ferrofluid. He performed a modification of the "leaping ferrofluid" demonstration in which he held a superstrong (14,800 gauss magnetic field strength) N52 rare earth neodymium magnet in his palm and slowly lowered that hand over an open bowl that was filled with ferrofluid.
RESULTS: As the magnet approached the liquid, the ferrofluid became magnetized. The liquid leaped from the bowl and contacted not only the magnet, but also the palmar surface of his hand and fingers, resulting in a black-brown dyschromia of the affected skin. The discoloration completely resolved after two weeks without any adverse sequellae.
CONCLUSION: Ferrofluid has numerous current and potential applications; in addition to being of value educationally and aesthetically (after being subjected to magnetic fields), it is also utilized for audio loudspeakers, medical innovations (such as a component of either a research tool, a diagnostic aid, or a treatment modality), and seals. Although the authors' patient did not experience any acute or chronic toxicity from his cutaneous exposure to ferrofluid, conservative follow-up for individuals who experience skin contact with ferromagnetic fluid may be appropriate.

Entities:  

Year:  2016        PMID: 27354890      PMCID: PMC4896823     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  9 in total

1.  Magnetic microparticles based on natural polymers.

Authors:  G Tataru; M Popa; J Desbrieres
Journal:  Int J Pharm       Date:  2010-11-12       Impact factor: 5.875

2.  Preparation and acute toxicology of nano-magnetic ferrofluid.

Authors:  Zefeng Xia; Guobin Wang; Kaixiong Tao; Jianxing Li; Yuan Tian
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 3.  Tattoos: a review of tattoo practices and potential treatment options for removal.

Authors:  Susan M Sweeney
Journal:  Curr Opin Pediatr       Date:  2006-08       Impact factor: 2.856

4.  Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging.

Authors:  Nasser Arsalani; Hassan Fattahi; Sophie Laurent; Carmen Burtea; Luce Vander Elst; Robert N Muller
Journal:  Contrast Media Mol Imaging       Date:  2012 Mar-Apr       Impact factor: 3.161

Review 5.  Magnetic microspheres: a vehicle for selective targeting of drugs.

Authors:  K J Widder; A E Senyei
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

6.  Biomedical applications of magnetic fluids. III. Antitumour effect of magnetic albumin microsphere-entrapped adriamycin on lung metastasis of AH 7974 in rats.

Authors:  K Sugibayashi; M Okumura; Y Morimoto
Journal:  Biomaterials       Date:  1982-07       Impact factor: 12.479

7.  Preclinical experiences with magnetic drug targeting: tolerance and efficacy.

Authors:  A S Lübbe; C Bergemann; W Huhnt; T Fricke; H Riess; J W Brock; D Huhn
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

Review 8.  Clinical applications of magnetic drug targeting.

Authors:  A S Lübbe; C Alexiou; C Bergemann
Journal:  J Surg Res       Date:  2001-02       Impact factor: 2.192

9.  Magnetic fluid hyperthermia modeling based on phantom measurements and realistic breast model.

Authors:  Arkadiusz Miaskowski; Bartosz Sawicki
Journal:  IEEE Trans Biomed Eng       Date:  2013-01-23       Impact factor: 4.538

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.